Metagenomi Therapeutics Statistics

Total Valuation

MGX has a market cap or net worth of $53.99 million. The enterprise value is -$66.16 million.

Market Cap	53.99M
Enterprise Value	-66.16M

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

MGX has 37.62 million shares outstanding. The number of shares has increased by 12.79% in one year.

Current Share Class	37.62M
Shares Outstanding	37.62M
Shares Change (YoY)	+12.79%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	10.50%
Owned by Institutions (%)	20.46%
Float	27.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.14
Forward PS	2.04
PB Ratio	0.35
P/TBV Ratio	0.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.22, with a Debt / Equity ratio of 0.26.

Current Ratio	7.22
Quick Ratio	7.08
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.67% and return on invested capital (ROIC) is -25.01%.

Return on Equity (ROE)	-44.67%
Return on Assets (ROA)	-21.99%
Return on Invested Capital (ROIC)	-25.01%
Return on Capital Employed (ROCE)	-48.45%
Weighted Average Cost of Capital (WACC)	4.21%
Revenue Per Employee	$211,849
Profits Per Employee	-$738,387
Employee Count	119
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	-58,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.53% in the last 52 weeks. The beta is 0.57, so MGX's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-17.53%
50-Day Moving Average	1.46
200-Day Moving Average	1.88
Relative Strength Index (RSI)	48.64
Average Volume (20 Days)	181,537

Short Selling Information

The latest short interest is 1.87 million, so 4.97% of the outstanding shares have been sold short.

Short Interest	1.87M
Short Previous Month	2.17M
Short % of Shares Out	4.97%
Short % of Float	6.85%
Short Ratio (days to cover)	9.57

Income Statement

In the last 12 months, MGX had revenue of $25.21 million and -$87.87 million in losses. Loss per share was -$2.36.

Revenue	25.21M
Gross Profit	-69.22M
Operating Income	-96.01M
Pretax Income	-87.93M
Net Income	-87.87M
EBITDA	-90.70M
EBIT	-96.01M
Loss Per Share	-$2.36

Full Income Statement

Balance Sheet

The company has $160.80 million in cash and $40.66 million in debt, giving a net cash position of $120.14 million or $3.19 per share.

Cash & Cash Equivalents	160.80M
Total Debt	40.66M
Net Cash	120.14M
Net Cash Per Share	$3.19
Equity (Book Value)	158.60M
Book Value Per Share	4.22
Working Capital	142.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$88.89 million and capital expenditures -$574,000, giving a free cash flow of -$89.47 million.

Operating Cash Flow	-88.89M
Capital Expenditures	-574,000
Depreciation & Amortization	5.32M
Net Borrowing	n/a
Free Cash Flow	-89.47M
FCF Per Share	-$2.38

Full Cash Flow Statement

Margins

Gross Margin	-274.59%
Operating Margin	-380.85%
Pretax Margin	-348.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MGX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.79%
Shareholder Yield	-12.79%
Earnings Yield	-162.76%
FCF Yield	-165.72%

Analyst Forecast

The average price target for MGX is $10.00, which is 596.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	596.86%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	48.86%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MGX has an Altman Z-Score of -1.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.78
Piotroski F-Score	1